scispace - formally typeset
M

Maxime Garcia

Researcher at Karolinska Institutet

Publications -  30
Citations -  997

Maxime Garcia is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Pipeline (software) & Interactome. The author has an hindex of 6, co-authored 30 publications receiving 354 citations. Previous affiliations of Maxime Garcia include French Institute of Health and Medical Research & University of Lyon.

Papers
More filters
Journal ArticleDOI

The nf-core framework for community-curated bioinformatics pipelines.

TL;DR: The nf-core framework is introduced as a means for the development of collaborative, peerreviewed, best-practice analysis pipelines that can be used across all institutions and research facilities and introduces a higher degree of portability as compared to custom in-house scripts.
Journal ArticleDOI

Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants.

TL;DR: Sarek is an open-source workflow to detect germline variants and somatic mutations based on sequencing data from WGS, whole-exome sequencing (WES), or gene panels that offers easy, efficient, and reproducible WGS analyses.
Posted ContentDOI

Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants

TL;DR: Sarek is a modular, comprehensive, and easy-to-install workflow, combining a range of software for the identification and annotation of single-nucleotide variants (SNVs), insertion and deletion variants (indels), structural variants, tumor sample heterogeneity, and karyotyping from germline or paired tumor/normal samples.
Posted ContentDOI

nf-core: Community curated bioinformatics pipelines

TL;DR: The nf-core framework as discussed by the authors provides a community-driven platform for the creation and development of best practice analysis pipelines written in the Nextflow language, which can be used across various institutions and research facilities.
Journal ArticleDOI

Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins.

TL;DR: The role of post-translational modifications (PTMs) mediated by members of the ubiquitin family are explored and gemcitabine-induced PTMs variations of relevant candidates are validated and the biological significance of such altered PTMs is demonstrated by studying in detail the sumoylation of SNIP1, one of these new targets.